Wave's RNA editing technology appears to have highly potential for the treatment of AATD, a genetic disorder with potential ...

Wave claims this is the first clinical data with a therapeutic RNA-editing drug in humans, an achievement that boosted its ...

Wave claims this is the first clinical data with a therapeutic RNA-editing drug in humans, an achievement that boosted its ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Buy rating on Wave Life Sciences (WVE – Research Report). The ...

Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...

Wave Life Sciences' stock soars on positive initial data showing the first-ever therapeutic RNA editing in humans in the phase Ib/IIa study of WVE-006 for AATD.

US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...

Versus Systems, ProQR, and Santech Holdings are the 3 Penny Stocks to watch on October 17, 2024, based on TipRanks’ Penny ...

Chardan Capital analyst Keay Nakae has reiterated their bullish stance on ADVM stock, giving a Buy rating on October 14. Keay Nakae has given ...

Researchers have mapped how small RNA molecules, such as the recently Nobel Prize-awarded microRNAs, control cell development in the human embryo during the first days after fertilization. The ...

US President Joe Biden announced a $425 million arms package for Kyiv Wednesday in a call with President Volodymyr Zelensky, ahead of a farewell visit to Berlin to discuss Ukraine, the White House ...